Product permission
Each brand is tied to a licensed composition and pack. Variations follow the proper regulatory path before stock is shipped.
Quality
Quality is the product. Everything else is packaging.
Our quality policy is to market batches that meet the registered specification, from manufacturing partners we have qualified, with a path back to the source if something goes wrong.
Quality policy
- Comply with the Drugs and Cosmetics Act, Rules, and applicable GMP and licensing expectations for marketed products.
- Qualify and periodically review contract manufacturers; freeze specifications before commercial orders.
- Control artwork, pack inserts, and claims so that what doctors read matches what regulators approved.
- Investigate complaints, deviations, and suspected counterfeits without delay.
- Train field staff never to over-claim, off-label promote, or hide safety information.
What we will not do
We will not switch a manufacturing site in silence, sell close-expired stock into retail as routine practice, or treat a pharmacist’s complaint as a sales objection. If we cannot defend a batch, we will not defend the sale.
Regulatory posture
Labelling
Schedule H / H1 warnings, storage, and composition appear as required. Marketing copy on this website is subordinate to the label.
Distribution
We work through authorised trade. Temperature-sensitive injectables must travel in validated cold chain where the dossier requires it.
Pharmacovigilance
If you are a doctor, pharmacist, or patient and you suspect an adverse event or product quality issue, tell us. Include the brand, batch number if available, and a description. Do not delay medical care to complete a form.
Email numachealthcare@yahoo.com with the subject line “Pharmacovigilance”, or use the form on the contact page.